Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Kidney Cancer treatment details. Chemotherapy. Immunotherapy. Tartu University Clinics, Tartu, Estonia

Survival: 8.1 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Xeloda
Country: Estonia
City/State/Province: Tartu
Hospital: Tartu University Clinics
Journal: Link
Date: 9/2004

Patients: This Phase II study involved 25 patients with advanced renal cell carcinoma, 18 men and 7 women. The median age was 57.2 years. Patients had inoperable or metastatic tumors. Eighteen patients had undergone a prior nephrectomy, but none had prior systemic treatment.

Treatment: The treatment consisted of the administration of the chemotherapy drug, capecitabine (xeloda) with interferon alpha-2A.

Toxicity: Grade 3-4 toxicities included fatigue, fever, anorexia, nausea, vomiting, hand-foot syndrome, diarrhea, weight loss, stomatitis, skin rash, myalgia, pain, colpitis, and hematological and enzyme toxicities.

Results: The median survival time was 248 days (8.1 months).

Correspondence: Peeter Padrik, MD

E-mail to a Friend Email Physician More Information